Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone and radiation for high-risk prostate cancer post-prostatectomy
NCT01079793Phase 2Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- May 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in prostate cancer (PCa), sponsored by UT Southwestern Medical Center. Planned start May 2010; status: withdrawn.
02
Drugs
ixabepilone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01079793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01079793.